A Meyer, R Buhl, S Kampf and H Magnussen
Krankenhaus Grosshansdorf, Zentrum fur Pneumologie and Thoraxchirurgie, Germany.

Idiopathic pulmonary fibrosis (IPF) is characterized by a huge alveolar oxidant burden and a deficiency of glutathione, a major antioxidant, in the pulmonary epithelial lining fluid (ELF). Therefore, a rational therapeutic strategy is to increase lung glutathione to augment the pulmonary antioxidant protective screen. To evaluate this concept, different doses of N-acetylcysteine (NAC), a glutathione precursor, were administered intravenously to eight patients with pulmonary fibrosis and six control subjects. In patients, bronchoalveolar lavage fluid (BALF) total glutathione increased significantly from 0.99 +/- 0.25 microM to 1.79 +/- 0.37 microM within 3 h following 1.8 g NAC, whereas 4.8 g NAC had no additional effect (1.47 +/- 0.34 microM). In the control subjects, NAC did not significantly alter BALF total glutathione (baseline: 0.79 +/- 0.17 microM, 600 mg NAC: 0.92 +/- 0.33 microM, 1.8 g NAC: 1.39 +/- 0.41 microM, 4.8 g NAC: 1.33 +/- 0.46 microM). The same was true in ELF, 1.8 g NAC significantly raised ELF total glutathione in patients from 186 +/- 47 microM to near normal levels (373 +/- 103 microM), with no further increase following 4.8 g NAC (293 +/- 62 microM). In the control subjects, ELF total glutathione remained unchanged independent of the NAC dose (baseline: 342 +/- 91 microM, 600 mg NAC: 385 +/- 135 microM, 1.8 g NAC: 633 +/- 220 microM, 4.8 g NAC: 646 +/- 263 microM). The increases in total glutathione were almost entirely due to increased levels of reduced glutathione, the form functional as an antioxidant. No adverse effects were noted.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. Behr and J. H. Ryu Pulmonary hypertension in interstitial lung disease Eur. Respir. J., June 1, 2008; 31(6): 1357 - 1367. [Abstract] [Full Text] [PDF]

				M. Sadegh Soltan-Sharifi, M. Mojtahedzadeh, A. Najafi, M. Reza Khajavi, M. Reza Rouini, M. Moradi, A. Mohammadirad, and M. Abdollahi Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms Human and Experimental Toxicology, September 1, 2007; 26(9): 697 - 703. [Abstract] [PDF]

				M. Demedts, J. Behr, R. Buhl, U. Costabel, R. Dekhuijzen, H. M. Jansen, W. MacNee, M. Thomeer, B. Wallaert, F. Laurent, et al. High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis. N. Engl. J. Med., November 24, 2005; 353(21): 2229 - 2242. [Abstract] [Full Text] [PDF]

				V. L. Kinnula, C. L. Fattman, R. J. Tan, and T. D. Oury Oxidative Stress in Pulmonary Fibrosis: A Possible Role for Redox Modulatory Therapy Am. J. Respir. Crit. Care Med., August 15, 2005; 172(4): 417 - 422. [Abstract] [Full Text] [PDF]

				M. Mata, A. Ruiz, M. Cerda, M. Martinez-Losa, J. Cortijo, F. Santangelo, A. Serrano-Mollar, A. Llombart-Bosch, and E.J. Morcillo Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats Eur. Respir. J., December 1, 2003; 22(6): 900 - 905. [Abstract] [Full Text] [PDF]

				K.M. Beeh, J. Beier, I.C. Haas, O. Kornmann, P. Micke, and R. Buhl Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis Eur. Respir. J., June 1, 2002; 19(6): 1119 - 1123. [Abstract] [Full Text] [PDF]

				J. Behr, B. Degenkolb, F. Krombach, and C. Vogelmeier Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine Eur. Respir. J., May 1, 2002; 19(5): 906 - 911. [Abstract] [Full Text] [PDF]

				J. Cortijo, M. Cerda-Nicolas, A. Serrano, G. Bioque, J.M. Estrela, F. Santangelo, A. Esteras, A. Llombart-Bosch, and E.J. Morcillo Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats Eur. Respir. J., June 1, 2001; 17(6): 1228 - 1235. [Abstract] [Full Text] [PDF]

				R.-M. Liu, Z. Borok, and H. J. Forman 4-Hydroxy-2-nonenal Increases {gamma}-Glutamylcysteine Synthetase Gene Expression in Alveolar Epithelial Cells Am. J. Respir. Cell Mol. Biol., April 1, 2001; 24(4): 499 - 505. [Abstract] [Full Text]

				K. Modelska, M. A. Matthay, L. A. S. Brown, E. Deutch, L. N. Lu, and J. F. Pittet Inhibition of beta -adrenergic-dependent alveolar epithelial clearance by oxidant mechanisms after hemorrhagic shock Am J Physiol Lung Cell Mol Physiol, May 1, 1999; 276(5): L844 - L857. [Abstract] [Full Text] [PDF]

				A. van der Vliet, C. A. O'Neill, C. E. Cross, J. M. Koostra, W. G. Volz, B. Halliwell, and S. Louie Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluids Am J Physiol Lung Cell Mol Physiol, February 1, 1999; 276(2): L289 - L296. [Abstract] [Full Text] [PDF]

				J Behr, K Maier, B Degenkolb, F Krombach, and C Vogelmeier Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1897 - 1901. [Abstract] [Full Text]